Actively Recruiting
Continuous Glucose Monitoring (CGM) After Kidney Transplantation
Led by Bo Feldt-Rasmussen · Updated on 2024-11-13
54
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes. The primary objective is to analyse differences in mean sensor glucose between these three groups. CGMs are applied to participants within 72 hours after kidney transplantation, with a total of 54 participants divided equally across the three groups (18 in each). Secondary objectives include assessing additional glucose profile indices, adherence to relevant guidelines, changes in HbA1c, the impact of immunosuppression and steroid dosage, and beta cell function.
CONDITIONS
Official Title
Continuous Glucose Monitoring (CGM) After Kidney Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent obtained before CGM application
- Male or female; age: 2 years
- Kidney transplantation
You will not qualify if you...
- Unable to cooperate to CGM the first ten days after surgery
- Allergic to plasters in CGM units
- Combined kidney and liver or pancreatic transplantation
- Graft loss/rejection within first 48 hours after transplantation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rigshospitalet
Copenhagen, DK, Denmark, 2100
Actively Recruiting
Research Team
I
Ida S Voss, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here